The global Targeting p53 Cancer Therapies market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Small Molecule Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Targeting p53 Cancer Therapies include Sibiono GeneTech, Kartos Therapeutics, SynerGene Therapeutics, MultiVir, Rain Oncology, Alieron Therapeutics, Aprea Therapeutics, Ascentage Pharma and Jc (Wuxi) Company, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The essence of p53-targeted therapy is to regain the "tumor suppressor function" of the mutated p53 protein, or indirectly protect the "tumor suppressor function" of p53 by inhibiting other targets that can inhibit the wild-type p53 protein.
This report aims to provide a comprehensive presentation of the global market for Targeting p53 Cancer Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeting p53 Cancer Therapies. This report contains market size and forecasts of Targeting p53 Cancer Therapies in global, including the following market information:
Global Targeting p53 Cancer Therapies Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Targeting p53 Cancer Therapies Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Targeting p53 Cancer Therapies companies in 2023 (%)
We surveyed the Targeting p53 Cancer Therapies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeting p53 Cancer Therapies Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeting p53 Cancer Therapies Market Segment Percentages, by Type, 2023 (%)
Small Molecule Drugs
Immunotherapy
Gene Therapy
Others
Global Targeting p53 Cancer Therapies Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeting p53 Cancer Therapies Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Targeting p53 Cancer Therapies Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeting p53 Cancer Therapies Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeting p53 Cancer Therapies revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Targeting p53 Cancer Therapies revenues share in global market, 2023 (%)
Key companies Targeting p53 Cancer Therapies sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Targeting p53 Cancer Therapies sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sibiono GeneTech
Kartos Therapeutics
SynerGene Therapeutics
MultiVir
Rain Oncology
Alieron Therapeutics
Aprea Therapeutics
Ascentage Pharma
Jc (Wuxi) Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeting p53 Cancer Therapies, market overview.
Chapter 2: Global Targeting p53 Cancer Therapies market size in revenue and volume.
Chapter 3: Detailed analysis of Targeting p53 Cancer Therapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeting p53 Cancer Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Targeting p53 Cancer Therapies capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Targeting p53 Cancer Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeting p53 Cancer Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeting p53 Cancer Therapies Overall Market Size
2.1 Global Targeting p53 Cancer Therapies Market Size: 2023 VS 2030
2.2 Global Targeting p53 Cancer Therapies Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Targeting p53 Cancer Therapies Sales: 2019-2030
3 Company Landscape
3.1 Top Targeting p53 Cancer Therapies Players in Global Market
3.2 Top Global Targeting p53 Cancer Therapies Companies Ranked by Revenue
3.3 Global Targeting p53 Cancer Therapies Revenue by Companies
3.4 Global Targeting p53 Cancer Therapies Sales by Companies
3.5 Global Targeting p53 Cancer Therapies Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Targeting p53 Cancer Therapies Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Targeting p53 Cancer Therapies Product Type
3.8 Tier 1, Tier 2 and Tier 3 Targeting p53 Cancer Therapies Players in Global Market
3.8.1 List of Global Tier 1 Targeting p53 Cancer Therapies Companies
3.8.2 List of Global Tier 2 and Tier 3 Targeting p53 Cancer Therapies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Targeting p53 Cancer Therapies Market Size Markets, 2023 & 2030
4.1.2 Small Molecule Drugs
4.1.3 Immunotherapy
4.1.4 Gene Therapy
4.1.5 Others
4.2 By Type - Global Targeting p53 Cancer Therapies Revenue & Forecasts
4.2.1 By Type - Global Targeting p53 Cancer Therapies Revenue, 2019-2024
4.2.2 By Type - Global Targeting p53 Cancer Therapies Revenue, 2025-2030
4.2.3 By Type - Global Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
4.3 By Type - Global Targeting p53 Cancer Therapies Sales & Forecasts
4.3.1 By Type - Global Targeting p53 Cancer Therapies Sales, 2019-2024
4.3.2 By Type - Global Targeting p53 Cancer Therapies Sales, 2025-2030
4.3.3 By Type - Global Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
4.4 By Type - Global Targeting p53 Cancer Therapies Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeting p53 Cancer Therapies Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Targeting p53 Cancer Therapies Revenue & Forecasts
5.2.1 By Application - Global Targeting p53 Cancer Therapies Revenue, 2019-2024
5.2.2 By Application - Global Targeting p53 Cancer Therapies Revenue, 2025-2030
5.2.3 By Application - Global Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
5.3 By Application - Global Targeting p53 Cancer Therapies Sales & Forecasts
5.3.1 By Application - Global Targeting p53 Cancer Therapies Sales, 2019-2024
5.3.2 By Application - Global Targeting p53 Cancer Therapies Sales, 2025-2030
5.3.3 By Application - Global Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
5.4 By Application - Global Targeting p53 Cancer Therapies Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Targeting p53 Cancer Therapies Market Size, 2023 & 2030
6.2 By Region - Global Targeting p53 Cancer Therapies Revenue & Forecasts
6.2.1 By Region - Global Targeting p53 Cancer Therapies Revenue, 2019-2024
6.2.2 By Region - Global Targeting p53 Cancer Therapies Revenue, 2025-2030
6.2.3 By Region - Global Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
6.3 By Region - Global Targeting p53 Cancer Therapies Sales & Forecasts
6.3.1 By Region - Global Targeting p53 Cancer Therapies Sales, 2019-2024
6.3.2 By Region - Global Targeting p53 Cancer Therapies Sales, 2025-2030
6.3.3 By Region - Global Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Targeting p53 Cancer Therapies Revenue, 2019-2030
6.4.2 By Country - North America Targeting p53 Cancer Therapies Sales, 2019-2030
6.4.3 US Targeting p53 Cancer Therapies Market Size, 2019-2030
6.4.4 Canada Targeting p53 Cancer Therapies Market Size, 2019-2030
6.4.5 Mexico Targeting p53 Cancer Therapies Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Targeting p53 Cancer Therapies Revenue, 2019-2030
6.5.2 By Country - Europe Targeting p53 Cancer Therapies Sales, 2019-2030
6.5.3 Germany Targeting p53 Cancer Therapies Market Size, 2019-2030
6.5.4 France Targeting p53 Cancer Therapies Market Size, 2019-2030
6.5.5 U.K. Targeting p53 Cancer Therapies Market Size, 2019-2030
6.5.6 Italy Targeting p53 Cancer Therapies Market Size, 2019-2030
6.5.7 Russia Targeting p53 Cancer Therapies Market Size, 2019-2030
6.5.8 Nordic Countries Targeting p53 Cancer Therapies Market Size, 2019-2030
6.5.9 Benelux Targeting p53 Cancer Therapies Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Targeting p53 Cancer Therapies Revenue, 2019-2030
6.6.2 By Region - Asia Targeting p53 Cancer Therapies Sales, 2019-2030
6.6.3 China Targeting p53 Cancer Therapies Market Size, 2019-2030
6.6.4 Japan Targeting p53 Cancer Therapies Market Size, 2019-2030
6.6.5 South Korea Targeting p53 Cancer Therapies Market Size, 2019-2030
6.6.6 Southeast Asia Targeting p53 Cancer Therapies Market Size, 2019-2030
6.6.7 India Targeting p53 Cancer Therapies Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Targeting p53 Cancer Therapies Revenue, 2019-2030
6.7.2 By Country - South America Targeting p53 Cancer Therapies Sales, 2019-2030
6.7.3 Brazil Targeting p53 Cancer Therapies Market Size, 2019-2030
6.7.4 Argentina Targeting p53 Cancer Therapies Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Targeting p53 Cancer Therapies Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Targeting p53 Cancer Therapies Sales, 2019-2030
6.8.3 Turkey Targeting p53 Cancer Therapies Market Size, 2019-2030
6.8.4 Israel Targeting p53 Cancer Therapies Market Size, 2019-2030
6.8.5 Saudi Arabia Targeting p53 Cancer Therapies Market Size, 2019-2030
6.8.6 UAE Targeting p53 Cancer Therapies Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Sibiono GeneTech
7.1.1 Sibiono GeneTech Company Summary
7.1.2 Sibiono GeneTech Business Overview
7.1.3 Sibiono GeneTech Targeting p53 Cancer Therapies Major Product Offerings
7.1.4 Sibiono GeneTech Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.1.5 Sibiono GeneTech Key News & Latest Developments
7.2 Kartos Therapeutics
7.2.1 Kartos Therapeutics Company Summary
7.2.2 Kartos Therapeutics Business Overview
7.2.3 Kartos Therapeutics Targeting p53 Cancer Therapies Major Product Offerings
7.2.4 Kartos Therapeutics Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.2.5 Kartos Therapeutics Key News & Latest Developments
7.3 SynerGene Therapeutics
7.3.1 SynerGene Therapeutics Company Summary
7.3.2 SynerGene Therapeutics Business Overview
7.3.3 SynerGene Therapeutics Targeting p53 Cancer Therapies Major Product Offerings
7.3.4 SynerGene Therapeutics Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.3.5 SynerGene Therapeutics Key News & Latest Developments
7.4 MultiVir
7.4.1 MultiVir Company Summary
7.4.2 MultiVir Business Overview
7.4.3 MultiVir Targeting p53 Cancer Therapies Major Product Offerings
7.4.4 MultiVir Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.4.5 MultiVir Key News & Latest Developments
7.5 Rain Oncology
7.5.1 Rain Oncology Company Summary
7.5.2 Rain Oncology Business Overview
7.5.3 Rain Oncology Targeting p53 Cancer Therapies Major Product Offerings
7.5.4 Rain Oncology Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.5.5 Rain Oncology Key News & Latest Developments
7.6 Alieron Therapeutics
7.6.1 Alieron Therapeutics Company Summary
7.6.2 Alieron Therapeutics Business Overview
7.6.3 Alieron Therapeutics Targeting p53 Cancer Therapies Major Product Offerings
7.6.4 Alieron Therapeutics Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.6.5 Alieron Therapeutics Key News & Latest Developments
7.7 Aprea Therapeutics
7.7.1 Aprea Therapeutics Company Summary
7.7.2 Aprea Therapeutics Business Overview
7.7.3 Aprea Therapeutics Targeting p53 Cancer Therapies Major Product Offerings
7.7.4 Aprea Therapeutics Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.7.5 Aprea Therapeutics Key News & Latest Developments
7.8 Ascentage Pharma
7.8.1 Ascentage Pharma Company Summary
7.8.2 Ascentage Pharma Business Overview
7.8.3 Ascentage Pharma Targeting p53 Cancer Therapies Major Product Offerings
7.8.4 Ascentage Pharma Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.8.5 Ascentage Pharma Key News & Latest Developments
7.9 Jc (Wuxi) Company
7.9.1 Jc (Wuxi) Company Company Summary
7.9.2 Jc (Wuxi) Company Business Overview
7.9.3 Jc (Wuxi) Company Targeting p53 Cancer Therapies Major Product Offerings
7.9.4 Jc (Wuxi) Company Targeting p53 Cancer Therapies Sales and Revenue in Global (2019-2024)
7.9.5 Jc (Wuxi) Company Key News & Latest Developments
8 Global Targeting p53 Cancer Therapies Production Capacity, Analysis
8.1 Global Targeting p53 Cancer Therapies Production Capacity, 2019-2030
8.2 Targeting p53 Cancer Therapies Production Capacity of Key Manufacturers in Global Market
8.3 Global Targeting p53 Cancer Therapies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Targeting p53 Cancer Therapies Supply Chain Analysis
10.1 Targeting p53 Cancer Therapies Industry Value Chain
10.2 Targeting p53 Cancer Therapies Upstream Market
10.3 Targeting p53 Cancer Therapies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Targeting p53 Cancer Therapies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Targeting p53 Cancer Therapies in Global Market
Table 2. Top Targeting p53 Cancer Therapies Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Targeting p53 Cancer Therapies Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Targeting p53 Cancer Therapies Revenue Share by Companies, 2019-2024
Table 5. Global Targeting p53 Cancer Therapies Sales by Companies, (K Units), 2019-2024
Table 6. Global Targeting p53 Cancer Therapies Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Targeting p53 Cancer Therapies Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Targeting p53 Cancer Therapies Product Type
Table 9. List of Global Tier 1 Targeting p53 Cancer Therapies Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeting p53 Cancer Therapies Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Targeting p53 Cancer Therapies Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Targeting p53 Cancer Therapies Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Targeting p53 Cancer Therapies Sales (K Units), 2019-2024
Table 15. By Type - Global Targeting p53 Cancer Therapies Sales (K Units), 2025-2030
Table 16. By Application ? Global Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Targeting p53 Cancer Therapies Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Targeting p53 Cancer Therapies Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Targeting p53 Cancer Therapies Sales (K Units), 2019-2024
Table 20. By Application - Global Targeting p53 Cancer Therapies Sales (K Units), 2025-2030
Table 21. By Region ? Global Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Targeting p53 Cancer Therapies Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Targeting p53 Cancer Therapies Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Targeting p53 Cancer Therapies Sales (K Units), 2019-2024
Table 25. By Region - Global Targeting p53 Cancer Therapies Sales (K Units), 2025-2030
Table 26. By Country - North America Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Targeting p53 Cancer Therapies Sales, (K Units), 2019-2024
Table 29. By Country - North America Targeting p53 Cancer Therapies Sales, (K Units), 2025-2030
Table 30. By Country - Europe Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Targeting p53 Cancer Therapies Sales, (K Units), 2019-2024
Table 33. By Country - Europe Targeting p53 Cancer Therapies Sales, (K Units), 2025-2030
Table 34. By Region - Asia Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Targeting p53 Cancer Therapies Sales, (K Units), 2019-2024
Table 37. By Region - Asia Targeting p53 Cancer Therapies Sales, (K Units), 2025-2030
Table 38. By Country - South America Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Targeting p53 Cancer Therapies Sales, (K Units), 2019-2024
Table 41. By Country - South America Targeting p53 Cancer Therapies Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Targeting p53 Cancer Therapies Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Targeting p53 Cancer Therapies Sales, (K Units), 2025-2030
Table 46. Sibiono GeneTech Company Summary
Table 47. Sibiono GeneTech Targeting p53 Cancer Therapies Product Offerings
Table 48. Sibiono GeneTech Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Sibiono GeneTech Key News & Latest Developments
Table 50. Kartos Therapeutics Company Summary
Table 51. Kartos Therapeutics Targeting p53 Cancer Therapies Product Offerings
Table 52. Kartos Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Kartos Therapeutics Key News & Latest Developments
Table 54. SynerGene Therapeutics Company Summary
Table 55. SynerGene Therapeutics Targeting p53 Cancer Therapies Product Offerings
Table 56. SynerGene Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. SynerGene Therapeutics Key News & Latest Developments
Table 58. MultiVir Company Summary
Table 59. MultiVir Targeting p53 Cancer Therapies Product Offerings
Table 60. MultiVir Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. MultiVir Key News & Latest Developments
Table 62. Rain Oncology Company Summary
Table 63. Rain Oncology Targeting p53 Cancer Therapies Product Offerings
Table 64. Rain Oncology Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Rain Oncology Key News & Latest Developments
Table 66. Alieron Therapeutics Company Summary
Table 67. Alieron Therapeutics Targeting p53 Cancer Therapies Product Offerings
Table 68. Alieron Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Alieron Therapeutics Key News & Latest Developments
Table 70. Aprea Therapeutics Company Summary
Table 71. Aprea Therapeutics Targeting p53 Cancer Therapies Product Offerings
Table 72. Aprea Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Aprea Therapeutics Key News & Latest Developments
Table 74. Ascentage Pharma Company Summary
Table 75. Ascentage Pharma Targeting p53 Cancer Therapies Product Offerings
Table 76. Ascentage Pharma Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Ascentage Pharma Key News & Latest Developments
Table 78. Jc (Wuxi) Company Company Summary
Table 79. Jc (Wuxi) Company Targeting p53 Cancer Therapies Product Offerings
Table 80. Jc (Wuxi) Company Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Jc (Wuxi) Company Key News & Latest Developments
Table 82. Targeting p53 Cancer Therapies Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 83. Global Targeting p53 Cancer Therapies Capacity Market Share of Key Manufacturers, 2022-2024
Table 84. Global Targeting p53 Cancer Therapies Production by Region, 2019-2024 (K Units)
Table 85. Global Targeting p53 Cancer Therapies Production by Region, 2025-2030 (K Units)
Table 86. Targeting p53 Cancer Therapies Market Opportunities & Trends in Global Market
Table 87. Targeting p53 Cancer Therapies Market Drivers in Global Market
Table 88. Targeting p53 Cancer Therapies Market Restraints in Global Market
Table 89. Targeting p53 Cancer Therapies Raw Materials
Table 90. Targeting p53 Cancer Therapies Raw Materials Suppliers in Global Market
Table 91. Typical Targeting p53 Cancer Therapies Downstream
Table 92. Targeting p53 Cancer Therapies Downstream Clients in Global Market
Table 93. Targeting p53 Cancer Therapies Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Targeting p53 Cancer Therapies Segment by Type in 2023
Figure 2. Targeting p53 Cancer Therapies Segment by Application in 2023
Figure 3. Global Targeting p53 Cancer Therapies Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Targeting p53 Cancer Therapies Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Targeting p53 Cancer Therapies Revenue, 2019-2030 (US$, Mn)
Figure 7. Targeting p53 Cancer Therapies Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Targeting p53 Cancer Therapies Revenue in 2023
Figure 9. By Type - Global Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 11. By Type - Global Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 12. By Type - Global Targeting p53 Cancer Therapies Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 15. By Application - Global Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 16. By Application - Global Targeting p53 Cancer Therapies Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Targeting p53 Cancer Therapies Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 20. By Region - Global Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 21. By Country - North America Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 22. By Country - North America Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 23. US Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 28. Germany Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 29. France Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 37. China Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 41. India Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 43. By Country - South America Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 44. Brazil Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Targeting p53 Cancer Therapies Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Targeting p53 Cancer Therapies Sales Market Share, 2019-2030
Figure 48. Turkey Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Targeting p53 Cancer Therapies Revenue, (US$, Mn), 2019-2030
Figure 52. Global Targeting p53 Cancer Therapies Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Targeting p53 Cancer Therapies by Region, 2023 VS 2030
Figure 54. Targeting p53 Cancer Therapies Industry Value Chain
Figure 55. Marketing Channels
